Net profit of Novelix Pharmaceuticals rose 307.69% to Rs 0.53 crore in the quarter ended September 2025 as against Rs 0.13 crore during the previous quarter ended September 2024. Sales rose 818.18% to Rs 36.36 crore in the quarter ended September 2025 as against Rs 3.96 crore during the previous quarter ended September 2024. ParticularsQuarter EndedSep. 2025Sep. 2024% Var. Sales36.363.96 818 OPM %1.935.30 - PBDT0.730.13 462 PBT0.720.13 454 NP0.530.13 308 Powered by Capital Market - Live News

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 13 November 2025.Powered by Capital Market - Live News

Novelix Pharmaceuticals announced that the 31th Annual General Meeting(AGM) of the company will be held on 19 September 2025.Powered by Capital Market - Live News

Net profit of Novelix Pharmaceuticals reported to Rs 0.11 crore in the quarter ended June 2025 as against net loss of Rs 0.35 crore during the previous quarter ended June 2024. Sales rose 3625.00% to Rs 22.35 crore in the quarter ended June 2025 as against Rs 0.60 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales22.350.60 3625 OPM %0.85-73.33 - PBDT0.19-0.34 LP PBT0.18-0.34 LP NP0.11-0.35 LP Powered by Capital Market - Live News

Novelix Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 August 2025.Powered by Capital Market - Live News